Delivery Order SPE2DB25D3008-SPE2DB25FRCRY
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,556,651 units of 0.3 mg epinephrine auto-injectors. The $2,903.70 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,678.32. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This award represents a child contract action under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.46 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector 2-packs. This contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement. The place of performance is also...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) with a ceiling value of $1,128.69. This competitive, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,652,889 units of Epinephrine 0.3 mg auto-injector 2s. The contract is valued at $8,098.21 and has a completion date of February 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,082.90. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of an Epinephrine 0.15 mg auto-injector product. The award, valued at $1,794.36, has an ultimate completion date of April 4, 2024. This delivery order was issued under an existing Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,642,206 Epinephrine 0.15 mg auto-injectors. The contract has a potential value of $4,485.90 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical products from its corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,371.05 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 0.3 mg epinephrine auto-injectors. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency awarded a $1,399.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office, with performance to be fulfilled from the company's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCRYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector pens (two-pack units) under a firm fixed price contract with a ceiling value of $2,533.79. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent capability to fulfill critical medical procurement requirements across multiple therapeutic domains for military and veteran healthcare systems, positioning it as a key vendor within the Defense Health Agency's supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/23/25 |